Compare HTX (HTX) vs Injective (INJ) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
HTX vs Injective — how do they compare? HTX trades at Rp0.0326 (market cap Rp29,12T, Rp422,82M 24h volume), while Injective trades at Rp80,442 (market cap Rp8,03T, Rp721,14M 24h volume). The key difference: HTX is far larger — about 3.6× Injective's market cap, and HTX's supply is capped (898,2T / 1.000T HTX (90%)) while Injective's keeps growing. Which is the better fit depends on your goals — on Pluang, investors hold HTX for 22 Days and Injective for 37 Days on average.
| HTX | INJ | |
|---|---|---|
Market Cap | Rp29,12T | Rp8,03T |
Volume (24h) | Rp422,82M | Rp721,14M |
Circulating Supply | 898,2T / 1.000T HTX (90%) | 100M INJ |
Typical Hold Time | 22 Days | 37 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
HTX token shows strong bullish momentum with current price at Rp0.0325 and market cap of Rp29.24T, supported by overwhelmingly positive moving average signals (13 buy vs 0 sell). The token has 90% of its maximum 1.000T supply in circulation with average hold time of 22 days. Technical indicators show ADX readings above 60 indicating strong trend strength, while RSI remains in neutral territory suggesting room for further upside.
Overall outlook is bullish with strong technical momentum, though limited fundamental updates and neutral oscillators suggest cautious optimism. Key opportunities include continued trend following, while risks involve high volatility and lack of recent ecosystem developments. Investors should monitor for protocol updates and exchange liquidity changes.
INJ is currently trading at Rp81,847 with a market cap of Rp8.18 trillion, showing bearish technical signals with moving averages indicating selling pressure while oscillators remain neutral. The token faces immediate resistance at Rp82,576 with support at Rp81,456. Recent on-chain data shows an average hold time of 37 days, suggesting moderate holding patterns among investors.
Overall outlook remains cautious with technical indicators favoring bearish momentum. Key opportunities include potential bounce from support levels, while major risks involve continued selling pressure and crypto market volatility. Investors should monitor network adoption metrics and exchange liquidity closely.
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About HTX
HTX is the native token of HTX DAO, a decentralized organization that supports the decentralized economy. It facilitates transactions, offers fee discounts, and provides access to exclusive features and services. Token holders can also participate in governance through voting. HTX is designed to support contributors, community programs, partnerships, and platform growth while promoting liquidity through voluntary pledging. Operating without formal registration, HTX DAO prioritizes autonomy, transparency, and inclusivity, making the HTX token essential for innovation, governance, and ecosystem growth in the blockchain space.
Read more on HTX →About Injective
Injective enables access to unlimited DeFi markets. Users can create any financial market on Injective's fast, cross-chain, zero gas fee, secure, and fully decentralized exchange protocol. The trading infrastructure of Injective is supported entirely by a central limit order book that integrates the user-friendly interface and speed of centralized exchanges with the transparency of decentralized exchanges. Native token INJ is a scarce asset that used for governance, exchange value capture, liquidity mining, and staking.
Read more on INJ →
